WALTHAM, Mass., May 4, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN)
(XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel
therapeutics to treat cancer and eye diseases, will report first quarter 2009
results on Monday, May 11, 2009. A conference call and webcast hosted by
OXiGENE management will begin at 4:30 p.m. EDT (1:30 p.m. PDT).
To listen to a live or archived version of the audio webcast, please log on to
the Company's website, www.oxigene.com. Under the "Investor" tab, select the
link to "Events and Presentations."
OXiGENE's earnings conference call can also be heard live by dialing
877-719-9801 in the United States and Canada, and 719-325-4766 for
international callers, five minutes prior to the beginning of the call. A
replay will be available starting at 7:30 p.m., EDT (4:30 p.m., PDT) on May 11,
2009 and ending at 12:00 midnight EDT (9:00 p.m., PDT) on Monday, May 25, 2009.
To access the replay, please dial (888) 203-1112 if calling from the United
States or Canada, or (719) 457-0820 from international locations. Please refer
to replay pass code 3405204.
About OXiGENE
OXiGENE is a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer and eye diseases. The Company's major focus is
developing vascular disrupting agents (VDAs) that selectively disrupt abnormal
blood vessels associated with solid tumor progression and visual impairment.
OXiGENE is dedicated to leveraging its intellectual property and therapeutic
development expertise to bring life-extending and life-enhancing medicines to
patients.
The OXiGENE, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=4969
CONTACT: OXiGENE
Investor and Media Contact:
Michelle Edwards
650-635-7006
medwards@oxigene.com
OXiGENE Announces First Quarter 2009 Earnings Conference Call and Webcast
| Source: Oxigene, Inc.